“P028 | WORSENING OF MIGRAINE AFTER DISCONTINUATION OF ANTI-CGRP MONOCLONAL ANTIBODIES: PATIENTS WITHOUT RECURRENCE FOR AT LEAST 6 MONTHS: M. Katsuki1|2, M. Romozzi3|4, S. Ooba5, Y. Matsumori6, K. Moran2, T. Ward2, S. Ishii7 | 1Nagaoka University of Technology, Japan; 2Insight Research Ireland Centre for Data Analytics, Ireland; 3Università Cattolica del Sacro Cuore, Italy; 4Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy; 5Ooba Clinic for Neurosurgery & Headache, Japan; 6Sendai Headache and Neurology Clinic, Japan; 7Daidai Clinic Kudanshita Headache Clinic, Japan” (2026) Confinia Cephalalgica, 36(s1). doi:10.4081/cc.2026.15984.